NanoVibronix, Inc. (NASDAQ:NAOV) Sees Significant Decline in Short Interest

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 38,700 shares, a decrease of 85.5% from the February 28th total of 267,600 shares. Approximately 4.9% of the shares of the company are short sold. Based on an average daily volume of 994,800 shares, the days-to-cover ratio is currently 0.0 days.

NanoVibronix Stock Down 0.9 %

NAOV traded down $0.04 during trading on Thursday, reaching $3.86. 7,267 shares of the company’s stock were exchanged, compared to its average volume of 268,464. NanoVibronix has a fifty-two week low of $1.92 and a fifty-two week high of $13.97. The company has a market capitalization of $3.05 million, a P/E ratio of -3.13 and a beta of 1.81. The business has a 50 day moving average price of $4.37 and a 200 day moving average price of $5.93.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.